InflaRx N.V. (IFRX) Reports Positive Data form Third Cohort of Phase IIa Open-Label Study with Vilobelimab
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/21/2026
- Nasdaq leads Wall Street gains as SpaceX, Super Micro boost AI sentiment
- Meta beats Q3 estimates, approves new nonvoting share class as AI spending surges
- Tesla stock up as automotive gross margin improves, free cash flow turns positive
- SpaceX, Tesla shares rise after Musk says committees exploring possible merger
- Brent falls as Iran's president discusses mediation with Pakistani army chief
| InferX Corporation (NASDAQ: IFRX) | Delayed: 1.55 +0.01 (0.65%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $1.54 | 52 Week High | $0.05 | |||
| Open | $1.55 | 52 Week Low | $0.00 | |||
| Day High | $1.61 | P/E | N/A | |||
| Day Low | $1.54 | EPS | $0.00 | |||
| Volume | 701,410 | |||||
